Preferential carcinogen-DNA adduct formation at codons 12 and 14 in the human K-ras gene and their possible

Wenwei Hu1, Zhaohui Feng, Moon-Shong Tang

  • 1Department of Environmental Medicine, New York University School of Medicine, Tuxedo, New York 10987, USA.

Biochemistry
|August 20, 2003
PubMed

Insights

Chemical carcinogens target specific sites in the K-ras gene, leading to mutations common in human cancers. Epigenetic factors, like cytosine methylation, explain this preferential DNA damage at K-ras codons 12 and 14.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Epigenetics

Background:

  • The K-ras gene is frequently mutated at codon 12 in human cancers.
  • Bulky chemical carcinogens preferentially form DNA adducts at K-ras codons 12 and 14 in normal human bronchial epithelial (NHBE) cells.
  • DNA adducts at K-ras codon 12 exhibit poor repair, contributing to high mutation rates.

Purpose of the Study:

  • To investigate the reasons behind preferential carcinogen-DNA adduct formation at K-ras codons 12 and 14.
  • To differentiate the roles of DNA sequence, chromatin structure, and epigenetic modifications in adduct formation.

Main Methods:

  • Carcinogen (benzo[a]pyrene diol epoxide, N-hydroxy-2-aminofluorene, aflatoxin B1 8,9-epoxide) modification of intact genomic DNA, fragmented DNA, and in vitro synthesized DNA fragments.
  • Analysis of DNA adduct distribution using UvrABC nuclease incision and ligation-mediated polymerase chain reaction.
  • Assessment of adduct formation in methylated and unmethylated DNA sequences.

Main Results:

  • Carcinogens preferentially formed adducts at K-ras codons 12 and 14 in intact and fragmented genomic DNA, but not in PCR-amplified DNA.
  • Cytosine methylation at the CpG site of codon 14 significantly enhanced adduct formation at this codon.
  • Methylation did not enhance adduct formation at codon 12, suggesting other epigenetic factors are involved.
  • The cytosine at the CpG site of codon 14 is highly methylated in NHBE cells.

Conclusions:

  • Cytosine methylation at CpG sites is a primary driver of preferential DNA damage at K-ras codon 14.
  • Epigenetic modifications beyond simple cytosine methylation likely contribute to preferential DNA damage at K-ras codon 12.
  • These findings elucidate mechanisms underlying K-ras mutations in cancer development.

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Nucleotide Excision Repair01:38

Nucleotide Excision Repair

DNA Distortion and Damage
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...